The Iris and Junming Le Foundation, founded in 2006, is a New York-based organization dedicated to advancing health initiatives in research and patient care. With a focus on supporting medical professionals engaged in research, the foundation aims to foster innovation and improve health outcomes. Funding for the foundation primarily comes from the royalty stream of the invention of Remicade, a groundbreaking medicine for autoimmune diseases, by Dr. Junming Le. In addition to medical initiatives, the foundation also supports various arts and humanitarian programs.
The Iris and Junming Le Foundation is actively involved in several major programs, including providing financial assistance for students to participate in international health programs, supporting research grants in neuroimaging and translational oncology, and funding the purchase of cutting-edge medical equipment for hospitals and research institutions. The foundation's diverse portfolio also includes investments in real estate and acquisitions to enhance its financial resources. Through its initiatives, the Iris and Junming Le Foundation is committed to making a lasting impact on medical research, education, and patient care.
Generated from the website